The FDA has given a fast-track designation to a gonorrhoea vaccine in development at GSK that could help turn the tide of the sexually-transmitted infection, which is on the rise around the world.

GSK has reported topline results from a phase 3 trial of its novel antibiotic gepotidacin that could spell the end of a decades-long drought in new oral therapies for gonorrhoea. In the EAGLE-1 ...

Some patients with prostate enlargement and cancer recount how their symptoms were mistaken for sexually transmitted ...

The country’s successful rollout of HIV anti-retroviral drugs has lulled many into a false sense of security around ...

A pharmacist has warned that people could confuse an STI with a common flu - and it could lead to serious health issues if ...

Srinagar- Late marriages, lack of awareness about contraception, rising obesity and changes in lifestyle are some of the ...

These numbers tell us a pretty high amount of Aussies are taking unnecessary risks. This has led to some pretty concerning ...

Boys waiting to undergo circumcision at a health facility in Embu/FILE. Parents taking their boys for circumcision this ...

EXCLUSIVE: Experts are concerned at the return of Dickensian diseases as well as the record high levels of sexually ...

A controversial advertisement designed to raise awareness about safe sex for gay men has been taken down after an influx of ...

A controversial advertisement designed to raise awareness about safe sex for gay men has been taken down after an influx of complaints about children seein ...

Research at the WHO Collaborating Centre for Gonorrhoea and other STIs is supported by grants from the WHO, the Örebro County Council Research Committee and the Foundation for Medical Research at ...